DAKLOS SP
DICLOFENAC 50 MG + PARA 325 MG + SERRATIOPEPTIDASE 15 MG TABS
Brand: DAKLOS SP
MRP
₹1150/-
Packaging
10*10 A/A
Form
Tablets
Description & Usage
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs is a medicine tablet in which Diclofenac, Paracetamol, and Serratiopeptidase are mixed together in precise formulation. This drug product has a good position in the product list segment of general medicine and pain management. A formulation with three medicines makes the entire product having a very complete and professional identity among other Pharma drugs.
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs are frequently offered in the portfolio of pharma companies who do business in PCD Pharma franchise, Third Party Manufacturing, Brand marketing and Pharma distribution and supply. Being in the tablet dosage form it is very easier to pack, store, transport and distribute through various business networks. If produced under all quality standards and with an eye-catching appearance, Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs could become a value-added addition to your product portfolio.
Composition Profile and Tablet Strength
Diclofenac 50mg + Paracetamol 325mg + Serratiopeptidase 15mg are the main ingredients in this tablet formulation. Diclofenac is one of the most sought out and highly used NSAIDs, Paracetamol is another much in use general medicine ingredient and Serratiopeptidase adds further value to the product and in the context of combination its relevance is understood.
The formulation usually involves adding few pharmaceutical excipients which is required for making a proper tablet hardness, stability and shape; disintegration of the tablet and it's shelf life. Well formulated tablets have all the three active Pharmaceutical Ingredients uniform in the entire formulation so that every tablet will deliver the same product strength as mentioned above.
The strength composition of 50mg, 325mg and 15mg makes it very appropriate for the products aimed at building a more complete general medicine/ pain management product list.
Manufacturing Quality and Standard Processing
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs need to be produced with utmost quality standards and in a highly professional set-up. Pharma companies that offer a strong product portfolio rely on quality and production that stands up to the required expectations. High quality and reliable pharma manufacturers ensure that raw material and production processes follow all stringent quality controls and standards.
Each stage starting from the procurement of raw material to the final packaging is monitored for all the important checkpoints which includes raw material analysis, granulation and tablet compression inspection, blending uniformity checks, hardness, disintegration test, finished products analysis, and inspection of the packaged material etc. Accuracy of blending these three different drug molecules is extremely important and it is taken care of during its formulation development and production.
Such manufacturing processes will ensure batch to batch consistency in the quality which is always looked for in pharmaceutical tablets. A good and quality producing Pharma manufacturer can definitely position your Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs higher in the market compared to the ones with inferior quality.
Packaging, Labeling and Brand Presentation
Proper and an attractive packaging of Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs will always make a good impact in the Pharma market. Blister or Strip packing is common for such formulations along with a well designed outer cartoon. Good quality packing also ensures the drug formulation's integrity for a longer shelf life.
A neatly printed label on each strip/ blister and carton carrying the brand name of the product, salts, strength and MRP along with other manufacturing details ( Batch No, Manufacturing Date, expiry Date, company name and address etc) provides the required legal and business information for all the stakeholders in the product supply chain. The appearance of the label also matters to present a professional look of the product.
This formulation when properly branded and packaged as per the client's expectations can truly become an eye catcher. Pharma companies focus a lot on the appearance of their drugs which in the long run can help in enhancing brand recall of the product among the healthcare professionals and patients.
Market Demand and Business Importance
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs is one such product that is in regular demand and thus finds a very important place in the product basket of any company dealing in general medicine products. For any pharma company that plans to focus on the pain management portfolio or to create a complete range of medicine, such a formulation is a must.
The formulation also adds business value for wholesalers and distributors. In fact, even third party manufacturers offer this formulation due to its steady market demand and good business scope for pharma companies that distribute pharma drugs and medicines under their own brands and franchise arrangements. The combination product has gained high importance for those firms wanting to present a truly balanced pharmaceutical product offering to the end user.
A product such as Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs made available with superior quality, consistent supply and decent profit margin will sure add value to any pharma enterprise.
PCD Pharma Franchise Scope
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs present great potential for those involved in the PCD Pharma franchise. Since this product has a good market demand, there is always scope for a good PCD Franchise Holder to market this medicine with appropriate support of MR aids like product cards, prescription pads, reminder cards and some visual aids.
Any pharma company that includes Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs in their PCD Franchise Portfolio, will be providing something valuable to the franchisers. If the PCD franchise offering includes monopoly rights in the territory and timely delivery of goods, then it will certainly be more lucrative for the franchise partners to distribute such drugs.
The triple-combination drug form and its popularity make Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs one of the core products required to start or strengthen your PCD Pharma business.
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs is a medicine tablet in which Diclofenac, Paracetamol, and Serratiopeptidase are mixed together in precise formulation. This drug product has a good position in the product list segment of general medicine and pain management. A formulation with three medicines makes the entire product having a very complete and professional identity among other Pharma drugs.
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs are frequently offered in the portfolio of pharma companies who do business in PCD Pharma franchise, Third Party Manufacturing, Brand marketing and Pharma distribution and supply. Being in the tablet dosage form it is very easier to pack, store, transport and distribute through various business networks. If produced under all quality standards and with an eye-catching appearance, Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs could become a value-added addition to your product portfolio.
Composition Profile and Tablet Strength
Diclofenac 50mg + Paracetamol 325mg + Serratiopeptidase 15mg are the main ingredients in this tablet formulation. Diclofenac is one of the most sought out and highly used NSAIDs, Paracetamol is another much in use general medicine ingredient and Serratiopeptidase adds further value to the product and in the context of combination its relevance is understood.
The formulation usually involves adding few pharmaceutical excipients which is required for making a proper tablet hardness, stability and shape; disintegration of the tablet and it's shelf life. Well formulated tablets have all the three active Pharmaceutical Ingredients uniform in the entire formulation so that every tablet will deliver the same product strength as mentioned above.
The strength composition of 50mg, 325mg and 15mg makes it very appropriate for the products aimed at building a more complete general medicine/ pain management product list.
Manufacturing Quality and Standard Processing
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs need to be produced with utmost quality standards and in a highly professional set-up. Pharma companies that offer a strong product portfolio rely on quality and production that stands up to the required expectations. High quality and reliable pharma manufacturers ensure that raw material and production processes follow all stringent quality controls and standards.
Each stage starting from the procurement of raw material to the final packaging is monitored for all the important checkpoints which includes raw material analysis, granulation and tablet compression inspection, blending uniformity checks, hardness, disintegration test, finished products analysis, and inspection of the packaged material etc. Accuracy of blending these three different drug molecules is extremely important and it is taken care of during its formulation development and production.
Such manufacturing processes will ensure batch to batch consistency in the quality which is always looked for in pharmaceutical tablets. A good and quality producing Pharma manufacturer can definitely position your Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs higher in the market compared to the ones with inferior quality.
Packaging, Labeling and Brand Presentation
Proper and an attractive packaging of Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs will always make a good impact in the Pharma market. Blister or Strip packing is common for such formulations along with a well designed outer cartoon. Good quality packing also ensures the drug formulation's integrity for a longer shelf life.
A neatly printed label on each strip/ blister and carton carrying the brand name of the product, salts, strength and MRP along with other manufacturing details ( Batch No, Manufacturing Date, expiry Date, company name and address etc) provides the required legal and business information for all the stakeholders in the product supply chain. The appearance of the label also matters to present a professional look of the product.
This formulation when properly branded and packaged as per the client's expectations can truly become an eye catcher. Pharma companies focus a lot on the appearance of their drugs which in the long run can help in enhancing brand recall of the product among the healthcare professionals and patients.
Market Demand and Business Importance
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs is one such product that is in regular demand and thus finds a very important place in the product basket of any company dealing in general medicine products. For any pharma company that plans to focus on the pain management portfolio or to create a complete range of medicine, such a formulation is a must.
The formulation also adds business value for wholesalers and distributors. In fact, even third party manufacturers offer this formulation due to its steady market demand and good business scope for pharma companies that distribute pharma drugs and medicines under their own brands and franchise arrangements. The combination product has gained high importance for those firms wanting to present a truly balanced pharmaceutical product offering to the end user.
A product such as Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs made available with superior quality, consistent supply and decent profit margin will sure add value to any pharma enterprise.
PCD Pharma Franchise Scope
Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs present great potential for those involved in the PCD Pharma franchise. Since this product has a good market demand, there is always scope for a good PCD Franchise Holder to market this medicine with appropriate support of MR aids like product cards, prescription pads, reminder cards and some visual aids.
Any pharma company that includes Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs in their PCD Franchise Portfolio, will be providing something valuable to the franchisers. If the PCD franchise offering includes monopoly rights in the territory and timely delivery of goods, then it will certainly be more lucrative for the franchise partners to distribute such drugs.
The triple-combination drug form and its popularity make Diclofenac 50 MG + Para 325 MG + Serratiopeptidase 15 MG Tabs one of the core products required to start or strengthen your PCD Pharma business.